561 related articles for article (PubMed ID: 24528911)
1. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy.
Murase JE; Heller MM; Butler DC
J Am Acad Dermatol; 2014 Mar; 70(3):401.e1-14; quiz 415. PubMed ID: 24528911
[TBL] [Abstract][Full Text] [Related]
2. Safety of dermatologic medications in pregnancy and lactation: Part II. Lactation.
Butler DC; Heller MM; Murase JE
J Am Acad Dermatol; 2014 Mar; 70(3):417.e1-10; quiz 427. PubMed ID: 24528912
[TBL] [Abstract][Full Text] [Related]
3. Dermatologic drugs, pregnancy, and lactation. A conservative guide.
Reed BR
Arch Dermatol; 1997 Jul; 133(7):894-8. PubMed ID: 9236528
[TBL] [Abstract][Full Text] [Related]
4. Caution advised in interpretation of US FDA risk classification for dermatological medications during pregnancy.
Wong JW; Heller MM; Murase JE
Dermatol Online J; 2012 Oct; 18(10):15. PubMed ID: 23122022
[TBL] [Abstract][Full Text] [Related]
5. Extent of medication use in breastfeeding women.
Stultz EE; Stokes JL; Shaffer ML; Paul IM; Berlin CM
Breastfeed Med; 2007 Sep; 2(3):145-51. PubMed ID: 17903100
[TBL] [Abstract][Full Text] [Related]
6. Safety of dermatologic medications in pregnancy and lactation: An Update - Part I: Pregnancy.
McMullan P; Yaghi M; Truong TM; Rothe M; Murase J; Grant-Kels JM
J Am Acad Dermatol; 2024 Jan; ():. PubMed ID: 38280679
[TBL] [Abstract][Full Text] [Related]
7. Safety of dermatologic medications in pregnancy and lactation: An Update - Part II: Lactation.
Yaghi M; McMullan P; Truong TM; Rothe M; Murase J; Grant-Kels JM
J Am Acad Dermatol; 2024 Jan; ():. PubMed ID: 38280680
[TBL] [Abstract][Full Text] [Related]
8. Safety classification systems used in dermatological medication risk counseling of pregnant and lactating patients: a case for an evidence-based approach.
Millsop JW; Heller MM; Murase JE
Dermatol Ther; 2013; 26(4):347-53. PubMed ID: 23914892
[TBL] [Abstract][Full Text] [Related]
9. [Dermatological treatment during pregnancy and lactation].
Kulczycka L; Woźniacka A
Postepy Hig Med Dosw (Online); 2010 Feb; 64():67-77. PubMed ID: 20173222
[TBL] [Abstract][Full Text] [Related]
10. The use of tumor necrosis factor inhibitors in pregnancy: what is the evidence?
Kivelevitch DN; Ryan C; Menter A
J Am Acad Dermatol; 2014 Oct; 71(4):829-31. PubMed ID: 25219705
[No Abstract] [Full Text] [Related]
11. Tumor necrosis factor-alfa inhibitors in pregnancy: to prescribe, or not to prescribe, that is the question.
Murase JE; Butler DC
J Am Acad Dermatol; 2014 Oct; 71(4):831-2. PubMed ID: 25219707
[No Abstract] [Full Text] [Related]
12. The use of dermatologic drugs in pregnancy and lactation.
Leachman SA; Reed BR
Dermatol Clin; 2006 Apr; 24(2):167-97, vi. PubMed ID: 16677965
[TBL] [Abstract][Full Text] [Related]
13. Drug safety: Pregnancy rating classifications and controversies.
Wilmer E; Chai S; Kroumpouzos G
Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079
[TBL] [Abstract][Full Text] [Related]
14. Drug use during pregnancy and breast-feeding. A classification system for drug information.
Berglund F; Flodh H; Lundborg P; Prame B; Sannerstedt R
Acta Obstet Gynecol Scand Suppl; 1984; 126():1-55. PubMed ID: 6393685
[TBL] [Abstract][Full Text] [Related]
15. Systemic medications used in treatment of common dermatological conditions: safety profile with respect to pregnancy, breast feeding and content in seminal fluid.
Brown SM; Aljefri K; Waas R; Hampton P
J Dermatolog Treat; 2019 Feb; 30(1):2-18. PubMed ID: 28092212
[TBL] [Abstract][Full Text] [Related]
16. The effect of medications on the lactating mother and her infant.
Bowes WA
Clin Obstet Gynecol; 1980 Dec; 23(4):1073-80. PubMed ID: 6160936
[TBL] [Abstract][Full Text] [Related]
17. Medications in pregnancy and lactation.
McCarter-Spaulding DE
MCN Am J Matern Child Nurs; 2005; 30(1):10-7; quiz 18-9. PubMed ID: 15622140
[TBL] [Abstract][Full Text] [Related]
18. Prescribing for the pregnant patient.
Mehta N; Chen K; Powrie RO
Cleve Clin J Med; 2014 Jun; 81(6):367-72. PubMed ID: 24891538
[TBL] [Abstract][Full Text] [Related]
19. Dermatologic agents during pregnancy and lactation: an update and clinical review.
Hale EK; Pomeranz MK
Int J Dermatol; 2002 Apr; 41(4):197-203. PubMed ID: 12031026
[No Abstract] [Full Text] [Related]
20. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
